Sicherer discussed how the study might shift clinical thinking in pediatric food allergy.
Scott Sicherer, MD, FAAAAI
Advertisement
Articles by Scott Sicherer, MD, FAAAAI
Sicherer discussed how findings from CAFETERIA may inform treatment decisions for children with high-threshold allergy.
A phase 2 trial found that 100% of children on peanut oral immunotherapy tolerated 9043 mg of peanuts, vs 10% in the avoidant group.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
AXIOMATIC-TKR: Milvexian Decouples Thrombosis, Hemostasis in DVT
2
SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes
3
REMAIN-1: Improved GLP-1-Induced Weight Loss Retention With Revita DMR System
4
FDA Grants Obinutuzumab Priority Review as Primary Membranous Nephropathy’s Potential First Therapy
5